- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03130608
Inspiratory Muscle Training Post-Liver Transplant
Comparison of Inspiratory Muscle Training and Usual Care in Individuals Post-Liver Transplant
Individuals with chronic liver disease develop significant muscle wasting that remains post-liver transplant. The transplant surgery additionally challenges respiratory mechanics. Respiratory muscle strength has been measured to be impaired in individuals post liver transplant. This study proposes an 8 week intervention designed to increase respiratory muscle strength and pulmonary function that we hypothesize will correlate to improved functional performance and quality of life post-liver transplant.
Pre-test post-test design, that will randomize subjects into an experimental group that will receive the inspiratory muscle strengthening exercise in addition to usual post-liver transplant care and a control group that will only receive the usual post-transplant care.
Up to 50 subjects will be recruited from the Post-Liver Transplant Outpatient Clinic at the Miami Transplant Institute.
The subjects will have repeated measurements of respiratory muscle strength, pulmonary function, functional mobility performance, and quality of life at baseline, 4 weeks, and 8 weeks.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- Miami Transplant Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1. Subjects must have undergone liver transplantation for chronic liver disease of any origin other than cancer.
Exclusion Criteria:
- Severe cardiopulmonary disease such as recent Myocardial infarction, Congestive Heart Failure, Pulmonary edema, Chronic Obstructive Pulmonary Disease, and Asthma,
- Severe osteoarthritis
- Blindness
- Wheelchair bound individuals
- Individuals with neurological / neuromuscular disorders including but not limited to: cerebral vascular accident, Parkinsonism, Alzheimer's disease, dystonia, multiple sclerosis, and polio.
- Severe Cognitive impairment where individuals cannot follow commands and are unable to sign informed consent -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Inspiratory Muscle Training
The experimental group will perform Inspiratory Muscle Training (IMT) using a THRESHOLD device, a simple hand held one way valve. In addition, the experimental group will gradually increase their activity as part of their usual care post-transplant. |
Subjects will breath through a hand held valve that has adjustable resistance to strengthen the muscles used for breathing.
Subjects will perform the exercise approximately 20-30 minutes, twice a day for 8 weeks.
|
No Intervention: Usual Care
Receive the usual post-liver transplant care of gradually increase their activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Maximal Inspiratory Pressure (MIP) at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks.
|
MIP is a measure of inspiratory muscle strength . Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Each measurement will be performed 3 times with the maximal score recorded. |
Baseline, 4 weeks, and 8 weeks.
|
Change from baseline Forced Expiratory Volume (FEV1) at 4 weeks and 8 weeks
Time Frame: Baseline, 4th week, and 8th week
|
FEV1 is how much air can be exhaled during a forced exhalation at one second. Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Each measurement will be performed 3 times with the maximal score recorded. |
Baseline, 4th week, and 8th week
|
Change from baseline 6 Minute Walk Distance at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
In a 100ft.
straight hallway the subject will walk back and forth, from one end to the other, as many times as they can in 6 minutes.
The subject will have the option to rest at any time during the six minutes.
The clock will keep running whether the subject is walking or resting.
The subject will be provided standardized cues to prevent unequal encouragement.
The distance walked over the 6 minutes will be recorded.
Throughout the walking test, the investigator will be walking nearby to guard patient from loss of balance or fall.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline 30 Second Chair Stand Repetitions at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
From a straight back chair the subject will come to a complete stand and then return to sitting with arms across chest.
The number of times the subject can stand in 30 seconds will be recorded.
The investigator will be standing nearby guarding the subject to protect from any loss of balance or fall.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Chronic Liver Disease Questionnaire (CLDQ) Score at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
This is a paper and pencil questionnaire consisting of 29 items in 6 domains: 1) Abdominal Symptoms 2) Activity: eating habits and movement of heavy objects 3) Emotional Function 4) Fatigue: perception of decreased energy and sleepiness 5) Systemic symptoms 6) Worry: concerns regarding disease progression and family.
Summary scores for each domain range from 1(most impaired) to 7 (least impaired).
All items refer to the previous 2 weeks.
Higher scores indicate less impairment.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Karnovsky Performance Status Score at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
This is a paper pencil questionnaire measuring functional impairment.
The questionnaire is divided into three groups for classifying patient's ability to work, to carry on normal activity, and to care for themselves.
The groups are further divided into eleven categories covering all level so functioning from normal (100) to dead (0).
The lower the Karnovsky score, the worse the functional ability and survival for most serious illness.
The liver transplant team records this measure prior to transplant.
We will obtained pre-transplant scores from medical record for use in correlational analysis.
This measure will also performed at baseline and post-testing.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Sustained Maximal Inspiratory Pressure (SMIP) at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
SMIP will be measured from residual volume to total lung capacity representing single breath work/endurance.
Inspiratory testing will be performed using a Micro Mouth Pressure Manometer.
92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips.
Subjects will wear a nose clip during testing.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Inspiratory Duration (ID) at 4 weeks and 8 weeks
Time Frame: Baseline, 4 weeks, and 8 weeks
|
ID is the inspiratory flow during maximal inspiration effort with an isokinetic like resistance from the mouthpiece.
Inspiratory testing will be performed using a Micro Mouth Pressure Manometer.
92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips.
Subjects will wear a nose clip during testing.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Maximal Expiratory Pressure (MEP) at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, and 8 weeks
|
MEP is a measure of expiratory muscle strength measured from total lung capacity.
Inspiratory testing will be performed using a Micro Mouth Pressure Manometer.
92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips.
Subjects will wear a nose clip during testing.
|
Baseline, 4 weeks, and 8 weeks
|
Change from baseline Forced Vital Capacity (FVC) at 4 weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, 8 weeks.
|
FVC is the total amount of air exhaled during a pulmonary function test. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Each measurement will be performed 3 times with the maximal score recorded. |
Baseline, 4 weeks, 8 weeks.
|
Change from baseline Forced Expiratory Flow (FEF25-75%) at 4weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, 8 weeks.
|
FEF25-75% is the flow rate at 25% to 75% of Forced Vital Capacity. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Each measurement will be performed 3 times with the maximal score recorded. |
Baseline, 4 weeks, 8 weeks.
|
Change from baseline Peak Expiratory Flow Rate (PEFR) at 4weeks and 8 weeks.
Time Frame: Baseline, 4 weeks, 8 weeks.
|
PEFR is a measure of how fast a person can exhale. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Each measurement will be performed 3 times with the maximal score recorded. |
Baseline, 4 weeks, 8 weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David W Mandel, PT, PhD, University of Miami Miller School of Medicine Department of Physical Therapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20170229
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of MilanCompleted
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
Riphah International UniversityCompletedMuscle Weakness ConditionPakistan
-
Damanhour UniversityCompletedNeuromuscular Electrical Stimulation | ICU Acquired Muscle WeaknessEgypt
Clinical Trials on Inspiratory Muscle Training
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
King Saud UniversityCompleted
-
Universidade do PortoUnknownMuscle Weakness | Dyspnea | Reactive Airways Dysfunction Syndrome (Disorder)Portugal
-
Gazi UniversityCompletedAllogeneic Hematopoietic Stem Cell Transplantation
-
Gazi UniversityCompleted
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownChronic Kidney Disease